Pyroptosis-mediator GSDMD promotes Parkinson's disease pathology via microglial activation and dopaminergic neuronal death

被引:6
|
作者
Zhang, Xiaoshuang [1 ,2 ]
Zhang, Yunhe [1 ,2 ]
Wang, Boya [1 ,2 ]
Xie, Chuantong [1 ,2 ]
Wang, Jinghui [1 ,2 ]
Fang, Rong [1 ,2 ]
Dong, Hongtian [1 ,2 ]
Fan, Guangchun [1 ,2 ]
Wang, Mengze [1 ,2 ]
He, Yongtao [1 ,2 ]
Shen, Chenye [1 ,2 ]
Duan, Yufei [1 ,2 ]
Zhao, Jiayin [1 ,2 ]
Liu, Zhaolin [1 ,2 ]
Li, Qing [1 ,2 ]
Ma, Yuanyuan [1 ,2 ]
Yu, Mei [1 ,2 ]
Wang, Jian [1 ,2 ]
Fei, Jian [3 ,4 ,5 ]
Xiao, Lei [1 ,2 ,5 ]
Huang, Fang [1 ,2 ,5 ]
机构
[1] Fudan Univ, Jingan Dist Ctr Hosp Shanghai, Dept Translat Neurosci, State Key Lab Med Neurobiol, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China
[2] Fudan Univ, Inst Brain Sci, MOE Frontiers Ctr Brain Sci, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China
[3] Tongji Univ, Sch Life Sci & Technol, 1239 Siping Rd, Shanghai 200092, Peoples R China
[4] Shanghai Model Organisms Ctr Inc, Shanghai Engn Res Ctr Model Organisms, Shanghai 201203, Peoples R China
[5] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金;
关键词
Parkinson's disease; GSDMD; Pyroptosis; Disulfiram; Dopaminergic neuron; Microglia; MPTP MOUSE MODEL; IN-VITRO MODEL; NLRP3; INFLAMMASOME; SUBSTANTIA-NIGRA; GASDERMIN-D; FLUORO-JADE; CELL-DEATH; SUPPRESSION; CASPASE-11; PROTECTS;
D O I
10.1016/j.bbi.2024.03.038
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
GSDMD-mediated pyroptosis occurs in the nigrostriatal pathway in Parkinson's disease animals, yet the role of GSDMD in neuroinflammation and death of dopaminergic neurons in Parkinson's disease remains elusive. Here, our in vivo and in vitro studies demonstrated that GSDMD, as a pyroptosis executor, contributed to glial reaction and death of dopaminergic neurons across different Parkinson's disease models. The ablation of the Gsdmd attenuated Parkinson's disease damage by reducing dopaminergic neuronal death, microglial activation, and detrimental transformation. Disulfiram, an inhibitor blocking GSDMD pore formation, efficiently curtailed pyroptosis, thereby lessening the pathology of Parkinson's disease. Additionally, a modification in GSDMD was identified in the blood of Parkinson's disease patients in contrast to healthy subjects. Therefore, the detected alteration in GSDMD within the blood of Parkinson's disease patients and the protective impact of disulfiram could be promising for the diagnostic and therapeutic approaches against Parkinson's disease.
引用
收藏
页码:129 / 145
页数:17
相关论文
共 50 条
  • [31] Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease
    Yoo, MS
    Chun, HS
    Son, JJ
    DeGiorgio, LA
    Kim, DJ
    Peng, C
    Son, JH
    MOLECULAR BRAIN RESEARCH, 2003, 110 (01): : 76 - 84
  • [32] Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson's Disease Model
    Sharma, Neha
    Nehru, Bimla
    MOLECULAR NEUROBIOLOGY, 2016, 53 (05) : 3326 - 3337
  • [33] Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson’s Disease Model
    Neha Sharma
    Bimla Nehru
    Molecular Neurobiology, 2016, 53 : 3326 - 3337
  • [34] Silibinin Prevents Dopaminergic Neuronal Loss in a Mouse Model of Parkinson's Disease Via Mitochondrial Stabilization
    Lee, Yujeong
    Park, Hee Ra
    Chun, Hye Jeong
    Lee, Jaewon
    JOURNAL OF NEUROSCIENCE RESEARCH, 2015, 93 (05) : 755 - 765
  • [35] Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease
    Gao, HM
    Jiang, J
    Wilson, B
    Zhang, W
    Hong, JS
    Liu, B
    JOURNAL OF NEUROCHEMISTRY, 2002, 81 (06) : 1285 - 1297
  • [36] Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models
    Huang, Bingxu
    Liu, Juxiong
    Ju, Chen
    Yang, Dongxue
    Chen, Guangxin
    Xu, Shiyao
    Zeng, Yalong
    Yan, Xuan
    Wang, Wei
    Liu, Dianfeng
    Fu, Shoupeng
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (10)
  • [37] Does increased excitatory drive from the subthalamic nucleus contribute to dopaminergic neuronal death in Parkinson's disease?
    Luquin, M. Rosario
    Saldise, Laura
    Guillen, Javier
    Belzunegui, Silvia
    San Sebastian, Waldy
    Izal, Amaya
    Garrido, Pablo
    Vazquez, Marianne
    EXPERIMENTAL NEUROLOGY, 2006, 201 (02) : 407 - 415
  • [38] Tyrosol exerts a protective effect against dopaminergic neuronal cell death in in vitro model of Parkinson's disease
    Dewapriya, Pradeep
    Himaya, S. W. A.
    Li, Yong-Xin
    Kim, Se-Kwon
    FOOD CHEMISTRY, 2013, 141 (02) : 1147 - 1157
  • [39] Protein arginine methyltransferase-1 stimulates dopaminergic neuronal cell death in a Parkinson's disease model
    Nho, Jong-Hyun
    Park, Min-Jung
    Park, Hyung Joon
    Lee, Jin Ho
    Choi, Joo-Hee
    Oh, Sang-Jin
    Lee, Young-Jin
    Yu, Young-Beob
    Kim, Hyung-Seok
    Kim, Dong-il
    Choi, Won-Seok
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 530 (02) : 389 - 395
  • [40] 4-Phenylbutyrate Mitigates the Motor Impairment and Dopaminergic Neuronal Death During Parkinson's Disease Pathology via Targeting VDAC1 Mediated Mitochondrial Function and Astrocytes Activation (vol 47, pg 3385, 2022)
    Tiwari, Shubhangini
    Gupta, Parul
    Singh, Abhishek
    Chaturvedi, Swati
    Wahajuddin, M.
    Mishra, Amit
    Singh, Sarika
    NEUROCHEMICAL RESEARCH, 2023, 48 (10) : 3251 - 3252